Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 264

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

Open access
Prensner, John R, Zhao, Shuang, Erho, Nicholas, Schipper, Matthew, Iyer, Matthew K, Dhanasekaran, Saravana M, Magi-Galluzzi, Cristina, Mehra, Rohit, Sahu, Anirban, Siddiqui, Javed, Davicioni, Elai, Den, Robert B, Dicker, Adam P, Karnes, R Jeffrey, Wei, John T, Klein, Eric A, Jenkins, Robert B, Chinnaiyan, Arul M, Feng, Felix Y·2014·The Lancet Oncology

Abstract

Background Improved clinical predictors for disease progression are needed for localized prostate cancer, where only a minority of patients experience poor outcomes. We undertake an unbiased large-scale analysis of genes associated with aggressive clinical course. Methods Prostate cancer samples, obtained from patients treated with radical prostatectomy at three academic institutions, were analyzed for gene expression using a clinical-grade, high-density Affymetrix GeneChip platform, encompassing >1 million genomic loci. Nomination of prognostic candidate genes was performed on a discovery cohort (n=545) and validated on three independent cohorts (n=463), totaling 1,008 patients. Molecular assays were performed in a CLIA-certified (Clinical Laboratory Improvement Amendments) laboratory facility. Multivariate analyses were performed for the primary endpoint of metastasis. The top prostate-specific gene was evaluated in urine samples from 230 patients using PCR. Findings Among all known genes, the long noncoding RNA SChLAP1 ranked first for elevated expression in patients with metastatic progression by receiver-operator-curve (ROC) area-under-the-curve (AUC) analyses. Of the top five prognostic genes, SChLAP1 was the only prostate-specific gene. Validation in three independent cohorts confirmed the prognostic value of SChLAP1 for metastasis. On multivariate modeling, SChLAP1 expression independently predicted metastasis within ten years (odds ratio (OR) = 2·45, 95% confidence interval (CI) 1·70 – 3·53), death within ten years (OR = 1·93, 95% CI 1·31 – 2·85), and biochemical recurrence within five years (OR = 1·76, 95% CI 1·28 – 2·41) with odds ratios comparable to Gleason score. Evaluation of SChLAP1 expression in 230 urine sediment samples with either biopsy-confirmed cancer or biopsy-negative tissue demonstrated increased incidence and expression of SChLAP1 RNA in patients at a higher risk for disease progression. Interpretation We perform the largest high-throughput, unbiased study of prostate cancer prognostic biomarkers to date and discover SChLAP1 as one of the best genes for the prediction of metastasis. We validate SChLAP1 extensively using a clinical-grade assay in a CLIA-certified laboratory. We show feasibility of a non-invasive urine test for SChLAP1, and suggest that SChLAP1 represents a very promising biomarker for aggressive clinical course. Funding Prostate Cancer Foundation, National Institutes of Health, Department of Defense, Early Detection Research Network, Doris Duke Charitable Foundation, and Howard Hughes Medical Institute.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(14)71113-1

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 264

Metadata

Authors
Prensner, J. R., Zhao, S., Erho, N., Schipper, M., Iyer, M. K., Dhanasekaran, S. M., Magi-Galluzzi, C., Mehra, R., Sahu, A., Siddiqui, J., Davicioni, E., Den, R. B., Dicker, A. P., Karnes, R. J., Wei, J. T., Klein, E. A., Jenkins, R. B., Chinnaiyan, A. M., & Feng, F. Y.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2014-12
Volume
15
Issue
13
Pages
1469-1480
ISSN
1470-2045 (ISSN-L)
OpenAlex
W2031320118
Cited by
264
References
7
FWCI
22.29
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. https://app.cochat.ai/papers/10.1016/s1470-2045(14)71113-1
The paper
Prensner, J. R., Zhao, S., Erho, N., Schipper, M., Iyer, M. K., Dhanasekaran, S. M., Magi-Galluzzi, C., Mehra, R., Sahu, A., Siddiqui, J., Davicioni, E., Den, R. B., Dicker, A. P., Karnes, R. J., Wei, J. T., Klein, E. A., Jenkins, R. B., Chinnaiyan, A. M., & Feng, F. Y. (2014). RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(14)71113-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.